Screener
Johnson & Johnson JNJ EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Johnson & Johnson’s reported figures.
The source filing: Johnson & Johnson’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000200406-26-000153
FAQ
- What is Johnson & Johnson's EBITDA?
- Johnson & Johnson (JNJ) reported EBITDA of $9.1B in Q2 2026.
- How has Johnson & Johnson's EBITDA changed year-over-year?
- Johnson & Johnson's EBITDA increased by 5.9% year-over-year, from $8.59B to $9.1B.
- What is the long-term trend for Johnson & Johnson's EBITDA?
- Over 4 years (2021 to 2025), Johnson & Johnson's EBITDA has grown at a 4.9% compound annual growth rate (CAGR), from $27.04B to $32.79B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Johnson & Johnson's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude